NEPAFEN

Therapeutic Class

Nonsteroidal anti-inflammatory prodrug (NSAID)

Indications

• Prevention and treatment of postoperative pain and inflammation associated with cataract surgery . Reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Chemical Composition

•Each ml contains Nepafenac INN 3 mg.

Packaging

•Each LDPE dropper bottle contains 5 ml sterile ophthalmic suspension.

Dosage & Administration

•Shake well before using. •For post-operative pain & inflammation: Instill 1 drop once daily 1 day prior to cataract surgery and continued on the day of surgery and through the first 2 weeks of the post-operative period. An additional drop should be administered 30 to 120 minutes prior to surgery.

Contraindications

•Contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formulation or to other NSAIDs.

Side Effects

•Reported side effects are foreign body sensation, lid margin crusting, ocular discomfort, ocular hyperemia etc.